期刊文献+

洛铂联合放疗对肺癌细胞杀伤作用的研究 被引量:8

Study of labaplatin combined with irradiation on lung cancer cell in vitro
下载PDF
导出
摘要 目的:研究洛铂联合放疗对非小细胞肺癌细胞的杀伤作用以及对细胞周期和凋亡的影响。方法:MTT法观察肺癌A549细胞增殖抑制,流式细胞仪检测细胞凋亡及细胞周期分布,蛋白免疫印迹检测Bcl-2和Bax蛋白表达。结果:洛铂对肺癌A549细胞有增殖抑制作用,且细胞毒性呈剂量依赖性;洛铂联合放疗组观察到有更高的细胞凋亡率和G2/M期阻滞;蛋白免疫印迹结果显示洛铂联合放疗组Bcl-2表达水平下降,促进凋亡诱导蛋白Bax表达水平升高。结论:洛铂有放疗增敏作用,作用机制可能与抑制Bcl-2表达、促进Bax表达、激活Bcl-2(Bax)-Caspase信号通路有关。 Objective:To study the effect of labaplatin combined with irradiation on non-small cell lung cancer cell line A549 and explore its radiosensitizing mechanism.Methods: MTT was used to examine the effect of labaplatin and / or irradiation on lung cancer cell line A549 proliferation.Flow cytometry was applied to detect the cell cycle distribution and cell apoptosis.Western blotting was used to observe the expression of Bcl-2 and Bax.Results: Lung cancer cell line A549 could be inhibited by labaplatin in a concentration dependent manner.G2 /M phase peak and apoptosis rate was the highest in cells treated with labaplatin combined with irradiation.Western blotting illustrated the decrease of Bcl-2 and the increase of Bax.Conclusion: Labaplatin could radiosensitize A549 cells and the possible mechanism might be related with inhibiting Bcl-2,inducing Bax expression and activating the Bcl-2(Bax)-caspase signaling way.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第5期669-672,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(30970792)
关键词 洛铂 肺癌 A549细胞 凋亡 labaplatin lung cancer A549 cell line apoptosis
  • 相关文献

参考文献9

二级参考文献31

共引文献62

同被引文献102

  • 1全吉钟,冯燕,王冬旭,黄京子.吉西他滨联合洛铂或顺铂一线治疗老年晚期非小细胞肺癌患者的疗效[J].中国老年学杂志,2014,34(5):1181-1182. 被引量:32
  • 2李琳琳,马锐,岳峥,刘文静.洛铂联合紫杉醇治疗晚期非小细胞肺癌近期疗效和安全性分析[J].中国实用内科杂志,2009,29(S2):90-91. 被引量:3
  • 3杨柳青,施毅,秦叔逵,钱军,韩宝惠,潘良熹,马胜林,李恩孝,蔡光蓉,李园,于国华,杨俊兰,王华庆,储大同.洛铂联合长春瑞滨治疗晚期非小细胞肺癌的临床研究[J].临床肿瘤学杂志,2006,11(12):890-894. 被引量:39
  • 4孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2010:153-156.
  • 5Crane CH, Varadhachary G, settle SH, et al. The integration of chemoradiation in the care of patient with localized pancreatic cancer[ J]. Cancer Radiother,2009,13 ( 2 ) : 123 - 143.
  • 6Ben-Josef E, Lawrence TS. Chemoradiotherapy for unresectable pancreatic cancer[ J]. Int J Clin Oncol,2008,13 (2) : 121- 126.
  • 7Huguet F, Girard N, Guerche CS, et al. Chemoradiotherapy in the management of locaXly advanced pancreatic carcinoma: aqualita- tire systematic review [ J ]. J Clin Oncol, 2009,27 ( 13 ) : 2269 - 2277.
  • 8Burris HA,Moore MJ,Andersen J, et al. Improvements in surviv- al and clinical benefit with gemcitabine as first-line therapy forpatients with advanced pancreas cancer: a randomized trial J. J Clin 0nco1,1997,15(6) :2403 -2413.
  • 9Huguet F, Girard N, Guerche CS, et al. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: aquatita- tire systematic review [ J ]. J Clin Oncol, 2009,27 ( 13 ) : 2269 - 2277.
  • 10NATIONAL COMPREHENSIVE CANCER NETWORK.NC-CN clinical practice guidelines in oncology(NCCN guidelines)small cell lung cancer(version 2.2012)[EB/OL].http://www.ncbi.nlm.nih.gov/pubmed/.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部